Impact of Dietary Patterns on Prognosis of Ovarian Cancer Patients During PARPi Maintenance

NCT07269574 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2025-12-08

No results posted yet for this study

Summary

The goal of this retrospective observational study is to evaluate the relationship between different dietary patterns (specifically low-carbohydrate diets) and the prognosis of patients with high-grade serous ovarian cancer (HGSOC) receiving first-line PARP inhibitor (PARPi) maintenance therapy. The main questions it aims to answer are:

* Is there an association between dietary patterns and patients' Progression-Free Survival (PFS)?
* Is there an association between dietary patterns and Overall Survival (OS)? This is a multicenter, retrospective cohort study. Researchers will review electronic medical records from 14 tertiary hospitals in China to identify women who received first-line PARP inhibitor maintenance for advanced high-grade serous ovarian cancer between 2020 and 2025, and collect information on baseline characteristics, treatments and follow-up outcomes.

Researchers will compare patients with a "low-carbohydrate diet pattern" to those with a "regular/high-carbohydrate diet pattern" to see if there are differences in treatment outcomes and survival.

Participants will:

* Have their clinical, pathological, and treatment data collected from electronic medical records.
* Complete a retrospective Food Frequency Questionnaire (FFQ) via phone or clinic visit to recall their dietary habits during the maintenance treatment period.
* Optionally provide a blood sample for nutrition and metabolic analysis. (For participants at the main study center only) No experimental drugs or specific diets will be given in this study. All anti-cancer treatments are decided by the treating physicians as part of routine clinical care.

Conditions

Sponsors & Collaborators

  • West China Second University Hospital

    collaborator OTHER
  • Peking University People's Hospital

    collaborator OTHER
  • Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center

    collaborator OTHER
  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    collaborator OTHER
  • The Affiliated Hospital of Qingdao University

    collaborator OTHER
  • Qilu Hospital of Shandong University

    collaborator OTHER
  • Shanghai First Maternity and Infant Hospital

    collaborator OTHER
  • First Affiliated Hospital, Sun Yat-Sen University

    collaborator OTHER
  • The First Affiliated Hospital of Soochow University

    collaborator OTHER
  • Henan Provincial People's Hospital

    collaborator OTHER
  • The First Affiliated Hospital of Henan University of Science and Technology

    collaborator OTHER
  • Women's Hospital of Zhejiang University

    collaborator UNKNOWN
  • Sun Yat-sen University Cancer Centre

    collaborator UNKNOWN
  • Tongji Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-11-27
Primary Completion
2026-11-30
Completion
2026-12-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07269574 on ClinicalTrials.gov